Pag-aaral pangklinika para sa Cirrhosis sa Minnesota
7 pag-aaral para sa Cirrhosis ang naghahanap ng mga kalahok sa mga site sa Minnesota.
Mga Lungsod sa Minnesota
Opisyal na teksto ng pag-aaral (English)
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Mayo Clinic, Rochester, Rochester
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07325526LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- MNGI Digestive Health, PA, Minneapolis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06632444Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Mayo Clinic, Rochester
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05832229National Liver Cancer Screening Trial
- Hennepin Healthcare, Minneapolis
- University of Minnesota, Minneapolis
Nagre-recruitPhase 4
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06084234Fibrosis Lessens After Metabolic Surgery
- Mayo Clinic, Rochester
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06374875Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Allina Health, Virginia Piper Cancer Institute, Coon Rapids
- Virginia Piper Cancer Institute Mercy Hospital-Unity Campus, Fridley
- VPCI Oncology Research, Minneapolis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05181826Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
- Mayo Clinic, Rochester
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 5, 2025 · NCT05490888Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.